Pieris Pharma (PIRS) Reports Q1 Loss of $0.19/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts PIRS Hot Sheet
Join SI Premium – FREE
Pieris Pharma (NASDAQ: PIRS) reported Q1 EPS of ($0.19), versus ($0.10) reported last year. Revenue for the quarter came in at $1.34 million, versus $1.25 million reported last year.
For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- ExxonMobil shares drop as crude oil prices tumble
- Marriott (MAR) Tops Q3 EPS by 19c; Guides EPS Higher
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
